Skip to content

Internally Irrigated and Externally Irrigated Surgical Guide Design for Placement of Dental Endosseous Implants

Evaluation of Internally Irrigated and Externally Irrigated Surgical Guide Design for Placement of Dental Endosseous Implants in Mandibular Posterior Region (Randomized Controlled Clinical Trial)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06866860
Enrollment
14
Registered
2025-03-10
Start date
2024-04-04
Completion date
2024-10-17
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant

Brief summary

Background: Patient specific surgical guides (PSG) have been widely used to achieve a precise 3D implant position. However, they prevent external cooling systems from reaching the osteotomy site sufficiently. So, heat generated during guided implant surgery is greater than free hand technique. Adding internal irrigation channel to the conventional surgical guides allows better diffusion of irrigation to the osteotomy site and reduces heat generation. Aim of the study: Is to introduce a patient specific surgical guide design with internal irrigation system and compare it to the conventional surgical guide with external irrigation clinically through bone temperature, implant stability and radiographically by CBCT through crestal bone loss and bone density.

Interventions

OTHERImplant surgical guide with internal irrigation

* Virtual surgical plan will be completed in the implant planning software (BlueSky plan, BlueSky Bio, USA), and the implant type, position, and sleeve height will be adjusted. * The entry point of the surgical drill into the alveolar bone will be identified. * An irrigation channel will be added, directed toward the entry point of the drill and adjusted to have the same diameter as the irrigation system tube.

OTHERConventional implant surgical guide with external irrigation

Virtual surgical plan will be completed in the implant planning software (BlueSky plan, BlueSky Bio, USA), and the implant type, position, and sleeve height will be adjusted. Conventional guide will be printed

Sponsors

Hams Hamed Abdelrahman
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Patient with missing mandibular posterior premolar or molar teeth. * Tooth extraction at the implant sites was performed at least 4 months before the surgery. * Residual alveolar bone height more than 10 mm. * With minimum alveolar bucco-lingual dimension of 6 mm. * Free from any systemic disease or local pathological lesions that may affect bone healing or contraindicate implant placement.

Exclusion criteria

* Severe atrophic alveolar ridge (height less than 10mm, width less than 6mm). * Bad oral hygiene ( Silness-Löe index (score 2-3). * Heavy smoker (smoke greater than or equal 25 cigarettes per day). * Presence of acute infections or periapical lesions in adjacent teeth. * Parafunctional habits. * Pregnant females.

Design outcomes

Primary

MeasureTime frameDescription
change in implant stabilityBaseline and 4 monthsOsstell will be used to objectively and non-invasively determine implant stability and to assess the progress of osseointegration without jeopardizing the healing process. This method is based on determining whether or not an implant is stable enough. The result is presented as an ISQ value of 1-100. The higher the ISQ, the more stable the implant
change in postoperative oedema2nd day, 1 week and 2 weeksThis will be measured as follows: None (no inflammation). Mild (intraoral swelling confined to the surgical field). Moderate (extraoral swelling in the surgical zone). Severe (extraoral swelling spreading beyond the surgical zone).

Secondary

MeasureTime frameDescription
Presence of intra or postoperative complications4 monthsBone overheating. Bone fenestration. Wound dehiscence. Peri-implantitis.
change in crestal bone lossbaseline and 4 monthsA CBCT was obtained immediately post operatively T1 and after 4 months T2 and evaluated using (BlueSky plan, BlueSky Bio, USA) to asses Crestal bone loss.
change in bone densitybaseline and 4 monthsA CBCT was obtained immediately post operatively T1 and after 4 months T2 and evaluated using (BlueSky plan, BlueSky Bio, USA) to asses Bone density using Hounsfield Unit (HU).

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026